Hannah Imlay

520 total citations
33 papers, 273 citations indexed

About

Hannah Imlay is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Hannah Imlay has authored 33 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 15 papers in Infectious Diseases and 11 papers in Oncology. Recurrent topics in Hannah Imlay's work include Cytomegalovirus and herpesvirus research (8 papers), Polyomavirus and related diseases (7 papers) and Full-Duplex Wireless Communications (5 papers). Hannah Imlay is often cited by papers focused on Cytomegalovirus and herpesvirus research (8 papers), Polyomavirus and related diseases (7 papers) and Full-Duplex Wireless Communications (5 papers). Hannah Imlay collaborates with scholars based in United States, Australia and Canada. Hannah Imlay's co-authors include Ajit P. Limaye, Daniel Kaul, Graeme N. Forrest, Steven A. Pergam, Krishna Rao, Monica A. Slavin, Brad Spellberg, Cynthia E. Fisher, Michael Boeckh and Robert M. Rakita and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Hannah Imlay

29 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hannah Imlay United States 10 156 102 78 34 32 33 273
Gülçin Telli Dizman Türkiye 9 42 0.3× 56 0.5× 121 1.6× 19 0.6× 3 0.1× 31 255
Klaudia Naegele Switzerland 10 130 0.8× 81 0.8× 113 1.4× 33 1.0× 15 248
Irma Hoyo Spain 9 289 1.9× 40 0.4× 121 1.6× 44 1.3× 15 400
Walter A. Tatarowicz United States 8 299 1.9× 82 0.8× 130 1.7× 15 0.4× 10 379
Alexa Debard France 6 83 0.5× 38 0.4× 107 1.4× 12 0.4× 19 0.6× 12 415
Christopher M. Saddler United States 11 285 1.8× 58 0.6× 150 1.9× 8 0.2× 38 329
Charlotte Pronier France 9 176 1.1× 31 0.3× 126 1.6× 4 0.1× 3 0.1× 29 305
Sara Mazzanti Italy 9 127 0.8× 18 0.2× 164 2.1× 19 0.6× 12 264
Orla Morrissey Australia 10 199 1.3× 71 0.7× 190 2.4× 15 0.4× 1 0.0× 26 329
Craig L K Boge United States 8 95 0.6× 27 0.3× 64 0.8× 7 0.2× 14 140

Countries citing papers authored by Hannah Imlay

Since Specialization
Citations

This map shows the geographic impact of Hannah Imlay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Imlay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Imlay more than expected).

Fields of papers citing papers by Hannah Imlay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Imlay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Imlay. The network helps show where Hannah Imlay may publish in the future.

Co-authorship network of co-authors of Hannah Imlay

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah Imlay. A scholar is included among the top collaborators of Hannah Imlay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah Imlay. Hannah Imlay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mendoza, Maria A. & Hannah Imlay. (2025). Polyomaviruses After Allogeneic Hematopoietic Stem Cell Transplantation. Viruses. 17(3). 403–403. 1 indexed citations
2.
Liu, Catherine, Emily A. Rosen, Hannah Imlay, et al.. (2025). Tackling antimicrobial resistance in people who are immunocompromised: leveraging diagnostic and antimicrobial stewardship. The Lancet Infectious Diseases. 26(1). e30–e48. 1 indexed citations
3.
Imlay, Hannah, et al.. (2024). In-person prospective audit and feedback on an oncology ward: development of an immunocompromised antimicrobial stewardship program. SHILAP Revista de lepidopterología. 4(1). e173–e173. 1 indexed citations
4.
Hand, Jonathan, et al.. (2024). Not Just an Oxymoron: The Utilitarian's Guide to Antimicrobial Stewardship in Transplant Infectious Diseases. Transplant Infectious Disease. 26(6). e14399–e14399.
5.
Imlay, Hannah, et al.. (2024). The role of empiric atypical antibiotic coverage in non-severe community-acquired pneumonia. SHILAP Revista de lepidopterología. 4(1). e214–e214.
6.
Imlay, Hannah, Chloe Bryson‐Cahn, Jeannie D. Chan, et al.. (2024). Antimicrobial stewardship to reduce overtreatment of asymptomatic bacteriuria in critical access hospitals: measuring a quality improvement intervention. Infection Control and Hospital Epidemiology. 46(2). 143–149. 1 indexed citations
7.
Imlay, Hannah, John W. Gnann, V. Ram Peddi, et al.. (2024). A randomized, placebo‐controlled, dose‐escalation phase I/II multicenter trial of low‐dose cidofovir for BK polyomavirus nephropathy. Transplant Infectious Disease. 26(6). e14367–e14367. 2 indexed citations
8.
Hand, Jonathan & Hannah Imlay. (2023). Antimicrobial Stewardship in Immunocompromised Patients. Infectious Disease Clinics of North America. 37(4). 823–851. 3 indexed citations
9.
Imlay, Hannah, et al.. (2023). Positivity of repeat nasal MRSA PCR screening: a single-center experience. SHILAP Revista de lepidopterología. 3(1). e226–e226.
10.
Yamauchi, Junji, Isaac E. Hall, Anshul Bhalla, et al.. (2023). Comparison of Short-Term Outcomes in Kidney Transplant Recipients from SARS-CoV-2–Infected versus Noninfected Deceased Donors. Clinical Journal of the American Society of Nephrology. 18(11). 1466–1475. 2 indexed citations
11.
Imlay, Hannah & Kimberly E. Hanson. (2023). Transplant-Related Infections. Infectious Disease Clinics of North America. 37(3). i–i.
12.
Imlay, Hannah, Paul Baum, Daniel C. Brennan, et al.. (2022). Consensus Definitions of BK Polyomavirus Nephropathy in Renal Transplant Recipients for Clinical Trials. Clinical Infectious Diseases. 75(7). 1210–1216. 20 indexed citations
13.
Imlay, Hannah, et al.. (2022). Shorter antibiotic courses in the immunocompromised: the impossible dream?. Clinical Microbiology and Infection. 29(2). 143–149. 18 indexed citations
14.
Imlay, Hannah, Elizabeth R. Duke, Anna Faino, et al.. (2022). BK Viremia and Changes in Estimated Glomerular Filtration Rate in Children and Young Adults after Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 29(3). 187.e1–187.e8. 2 indexed citations
15.
Imlay, Hannah & Brad Spellberg. (2022). Shorter is better: The case for short antibiotic courses for common infections in solid organ transplant recipients. Transplant Infectious Disease. 24(5). e13896–e13896. 8 indexed citations
16.
Vutien, Philip, James D. Perkins, Scott W. Biggins, et al.. (2021). Association of Donor and Recipient Cytomegalovirus Serostatus on Graft and Patient Survival in Liver Transplant Recipients. Liver Transplantation. 27(9). 1302–1311. 7 indexed citations
17.
Ulrich, Robert J., et al.. (2019). Clostridioides difficile Enteritis in Patients Following Total Colectomy—a Rare but Genuine Clinical Entity. Open Forum Infectious Diseases. 6(11). ofz409–ofz409. 3 indexed citations
18.
Imlay, Hannah, Kathryn S. Whitaker, Cynthia E. Fisher, & Ajit P. Limaye. (2018). Clinical characteristics and outcomes of late‐onset BK virus nephropathy in kidney and kidney‐pancreas transplant recipients. Transplant Infectious Disease. 20(4). e12928–e12928. 10 indexed citations
19.
Patel, Twisha S, Hannah Imlay, Daniel Kaul, Linda J. Stuckey, & Kevin Gregg. (2017). Ganciclovir-resistant CMV (GCV-R CMV) Infection Leads to Poor Clinical Outcomes and Economic Burden of Ganciclovir-resistant Cytomegalovirus Infection in Lung Transplant Recipients. Open Forum Infectious Diseases. 4(suppl_1). S730–S730. 7 indexed citations
20.
Steinbrink, Julie M., Hannah Imlay, Krishna Rao, & James Riddell. (2016). Identifying Causes of Antiretroviral Treatment Failure in HIV-Infected Patients. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gülçin Telli Dizman Breakdown of academic impact, for papers by Klaudia Naegele Breakdown of academic impact, for papers by Irma Hoyo Breakdown of academic impact, for papers by Walter A. Tatarowicz Breakdown of academic impact, for papers by Alexa Debard Breakdown of academic impact, for papers by Christopher M. Saddler Breakdown of academic impact, for papers by Charlotte Pronier Breakdown of academic impact, for papers by Sara Mazzanti Breakdown of academic impact, for papers by Orla Morrissey Breakdown of academic impact, for papers by Craig L K Boge
Rankless by CCL
2026